Yuliya Prokopets - Kiev, Ukraine

Yuliya Prokopets – Head of the Biotechnological Laboratory at the Institute of Cell Therapy

About Yuliya Prokopets

Yuliya Prokopets is a highly distinguished and experienced molecular biologist currently serving as the Head of the Biotechnological Laboratory at the prestigious Institute of Cell Therapy in Ukraine. With a profound academic background and specialized training in the intricate fields of biology and molecular biology, she plays a critical, behind-the-scenes role in advancing modern regenerative medicine. Armed with a Master of Biology degree from the esteemed Taras Shevchenko National University of Kyiv, Yuliya Prokopets brings over a decade of rigorous scientific expertise to the biotechnology sector, specializing in the development, validation, and quality control of advanced cellular therapies.

Over her 10 years of professional experience—including 5 dedicated years in her current leadership position—Yuliya has become a vital asset to the Institute of Cell Therapy. Her primary professional focus revolves around the highly specialized production of preparations of nucleated cells derived from umbilical cord blood, as well as the creation of therapeutic placental preparations. Her role ensures that all cellular and biological materials used in life-changing regenerative therapies meet the highest standards of safety, viability, and efficacy. Yuliya’s unwavering commitment to the strict validation and continuous monitoring of all stages of umbilical cord blood and placenta processing ensures that patients receiving treatments derived from her laboratory achieve the best possible medical outcomes. She stands at the forefront of biotechnological innovation, bridging the gap between molecular science and practical, clinical cell therapy applications.

Medical Expertise & Specializations

As the Head of the Biotechnological Laboratory, Yuliya Prokopets focuses her unparalleled expertise on the microscopic, cellular, and molecular mechanisms that make modern regenerative medicine possible. Her core specialization in Molecular Biology provides the foundational science required to safely extract, process, and cryopreserve human stem cells. The Institute of Cell Therapy relies heavily on her biotechnological acumen to manage the delicate processing of biological tissues that hold massive potential for healing and tissue regeneration. The intersection of molecular biology and cell therapy is complex; it requires an exact understanding of cellular structures, genetic material, and the environmental conditions necessary to keep biological materials viable outside the human body.

Yuliya’s leadership in the laboratory involves the complete oversight of biotechnological workflows. The processing of umbilical cord blood and placental tissue must be executed flawlessly to prevent contamination and to preserve the maximum number of active, nucleated stem cells. Under her meticulous supervision, the laboratory monitors every single phase of the cellular extraction process. Her work guarantees the biological integrity of the preparations that clinicians later use to treat a myriad of complex diseases, immune disorders, and age-related degenerative conditions.

Conditions Targeted by Laboratory Preparations

While Yuliya Prokopets is a laboratory specialist and molecular biologist rather than a forward-facing clinician, the cellular preparations she meticulously produces are instrumental in treating a wide array of severe medical conditions. By isolating high-quality stem cells and placental extracts, her work directly supports the treatment of:

• Hematological and Immune Disorders: Nucleated cells from umbilical cord blood are rich in hematopoietic stem cells, which are fundamental in reconstituting the immune system and treating leukemias, lymphomas, and various severe anemias.
• Degenerative Joint and Bone Diseases: The biological materials processed in her laboratory contain powerful growth factors used in orthopedics to stimulate cartilage repair, reduce severe inflammation, and treat osteoarthritis.
• Neurological Conditions: Advanced cellular preparations are increasingly utilized in the management and regenerative treatment of neurodegenerative diseases, providing neuroprotective benefits derived from placental extracts.
• Tissue Damage and Wound Healing: Placental preparations manufactured under Yuliya’s monitoring are highly potent in promoting rapid tissue regeneration, making them invaluable for treating severe burns, chronic non-healing ulcers, and surgical recovery.
• Anti-Aging and Preventive Medicine: As part of comprehensive revitalization programs, the biologically active substances and nucleated cells processed at the Institute of Cell Therapy help restore systemic vitality and combat cellular aging.

Laboratory Procedures & Biotechnological Processes Performed

The daily operations managed by Yuliya Prokopets involve highly sophisticated molecular biology techniques and rigorous quality assurance protocols. Her core procedural focuses include:

• Production of Nucleated Cord Blood Cells: This intricate procedure involves the careful separation of red blood cells and plasma from umbilical cord blood to isolate the highly valuable "buffy coat," which contains the concentrated nucleated stem cells vital for cellular therapies.
• Processing of Placental Preparations: Yuliya oversees the complex biological processing of placental tissue, breaking it down into therapeutic extracts and cellular structures while preserving its rich matrix of growth factors, cytokines, and regenerative proteins.
• Validation of Cellular Processing: Every step of the cell extraction protocol is validated to ensure it meets strict international and institutional biosafety standards. This involves verifying that the cell yield, viability, and sterility are optimal.
• Continuous Monitoring Protocols: She implements and monitors continuous quality control systems throughout the biotechnological laboratory. This includes the supervision of cryopreservation techniques, ensuring that the processed cord blood and placenta can be stored safely in liquid nitrogen for decades without losing their therapeutic properties.
• Molecular Profiling and Biosafety Testing: Utilizing her background in molecular biology, she ensures that all derived biological products undergo rigorous testing for infectious agents, genetic stability, and overall cellular health before they are cleared for clinical application.

Education and Training

The foundation of Yuliya Prokopets's exceptional career in biotechnology is built upon a rigorous and prestigious academic background. Her deep understanding of living systems at the molecular level allows her to innovate and maintain the highest standards in cell therapy laboratory practices.

• Master of Biology: Taras Shevchenko National University of Kyiv (КНУ ім. Тараса Шевченка). Graduating from one of Ukraine's most prestigious and historic educational institutions, Yuliya received comprehensive training in biological sciences, genetics, and laboratory research methodologies.
• Specialization in Molecular Biology: Dedicated academic and professional focus on the molecular mechanisms of cells, DNA/RNA processes, and biotechnological applications in human health.
• Professional Experience: Over 10 years of total professional experience in the field of biology and laboratory sciences, accumulating vast practical knowledge in handling human cellular materials.
• Leadership Role: 5 years serving in the crucial leadership role as the Head of the Biotechnological Laboratory at the Institute of Cell Therapy, overseeing a team of specialists and managing complex bio-processing systems.

Frequently Asked Questions (FAQ)